PTCT PTC Therapeutics Inc

PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.

$47.55  -0.71 (-1.47%)
As of 04/09/2021 15:59:52 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/20/2013
Outstanding shares:  70,322,320
Average volume:  557,210
Market cap:   $3,347,342,432
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    69366J200
ISIN:        US69366J2006
Sedol:      B17VCN9
Valuation   (See tab for details)
PE ratio:   -7.64
PB ratio:   6.89
PS ratio:   8.79
Return on equity:   -90.91%
Net income %:   -115.07%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy